These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3952542)

  • 1. In vitro detection of heparin-induced humoral antiplatelet activity.
    Feffer SE; Carmosino LS; Lin JH; Fox RS
    South Med J; 1986 Mar; 79(3):315-8. PubMed ID: 3952542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets.
    Chong BH; Grace CS; Rozenberg MC
    Br J Haematol; 1981 Dec; 49(4):531-40. PubMed ID: 7317283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced immune thrombocytopenia.
    Babcock RB; Dumper CW; Scharfman WB
    N Engl J Med; 1976 Jul; 295(5):237-41. PubMed ID: 945459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies.
    Laster JL; Nichols WK; Silver D
    Arch Intern Med; 1989 Oct; 149(10):2285-7. PubMed ID: 2802894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated catheters and heparin-induced thrombocytopenia.
    Laster J; Silver D
    J Vasc Surg; 1988 May; 7(5):667-72. PubMed ID: 3367431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods.
    Fratantoni JC; Pollet R; Gralnick HR
    Blood; 1975 Mar; 45(3):395-401. PubMed ID: 1115835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin induced platelet aggregation: in vitro confirmation of thrombotic complications associated with heparin therapy.
    Hussey CV; Bernhard VM; McLean MR; Fobian JE
    Ann Clin Lab Sci; 1979; 9(6):487-93. PubMed ID: 518011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism.
    Stead RB; Schafer AI; Rosenberg RD; Handin RI; Josa M; Khuri SF
    Am J Med; 1984 Jul; 77(1):185-8. PubMed ID: 6741980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets.
    Chong BH; Castaldi PA
    Br J Haematol; 1986 Oct; 64(2):347-54. PubMed ID: 3778828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia.
    Pfueller SL; David R
    Br J Haematol; 1986 Sep; 64(1):149-59. PubMed ID: 3756098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia.
    Isenhart CE; Brandt JT
    Am J Clin Pathol; 1993 Mar; 99(3):324-30. PubMed ID: 8447295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
    J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative platelet defect in a case of heparin-induced thrombocytopenia.
    Chong BH; Grace CS; Rozenberg MC; Castaldi PA
    Scand J Haematol; 1983 May; 30(5):427-9. PubMed ID: 6407097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reexposure to heparin of patients with heparin-associated antibodies.
    Laster J; Elfrink R; Silver D
    J Vasc Surg; 1989 May; 9(5):677-81; discussion 681-2. PubMed ID: 2724455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia--association with a platelet aggregating factor and cross-sensitivity to bovine and porcine heparin.
    Guay DR; Richard A
    Drug Intell Clin Pharm; 1984 May; 18(5):398-401. PubMed ID: 6723517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin-induced thrombopenia: significance and difficulties of precise identification of the immunologic mechanism].
    Samama MM; Elalamy I; Lecrubier C; Potevin F; Horellou MH; Conard J
    Bull Acad Natl Med; 1998; 182(7):1517-33; discussion 1534-6. PubMed ID: 9916345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-related immune thrombocytopenia. Studies of antibody-heparin specificity.
    Trowbridge AA; Caraveo J; Green JB; Amaral B; Stone MJ
    Am J Med; 1978 Aug; 65(2):277-83. PubMed ID: 80131
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.
    Palatianos G; Michalis A; Alivizatos P; Lacoumenda S; Geroulanos S; Karabinis A; Iliopoulou E; Soufla G; Kanthou C; Khoury M; Sfyrakis P; Stavridis G; Astras G; Vassili M; Antzaka C; Marathias K; Kriaras I; Tasouli A; Papadopoulos K; Katafygioti M; Matoula N; Angelidis A; Melissari E
    Am J Hematol; 2015 Jul; 90(7):608-17. PubMed ID: 25808486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.